Atypical cannabinoid ligands O-1602 and O-1918 administered chronically in diet-induced obesity
Abstract Atypical cannabinoid compounds O-1602 and O-1918 are ligands for the putative cannabinoid receptors G protein-coupled receptor 55 and G…
Abstract Atypical cannabinoid compounds O-1602 and O-1918 are ligands for the putative cannabinoid receptors G protein-coupled receptor 55 and G…
Abstract The current treatment of glioblastoma is not sufficient, since they are heterogeneous and often resistant to chemotherapy. Earlier studies…
Abstract We conducted a review of systematic reviews (SRs) and randomized-controlled trials (RCTs) to analyze efficacy and safety of cannabis-based…
Abstract Background: The endocannabinoid system (ECS) is a major regulator of synaptic plasticity and neuromodulation. Alterations of the ECS have…
Abstract Background: Chronic pain affects a significant proportion of the population and presents a major challenge to clinicians and pain…
Abstract Background: A 239-question cross-sectional survey was sent out via email in January 2017 to gather comprehensive information on cannabis…
Abstract Hemp seed (Fructus cannabis) is rich in lignanamides, and initial biological screening tests showed their potential anti-inflammatory and anti-oxidative…
Abstract Electronic supplementary material: The online version of this article (10.1007/s00406-019-00981-7) contains supplementary material, which is available to authorized users.…
Abstract There is an increased interest in the use of cannabinoids in the treatment of symptoms in cancer and palliative…
Abstract Background: Healthcare providers play a critical role in facilitating patient access to medical cannabis. However, previous surveys suggest only…